"Researchers are making progress toward understanding how some cases of glaucoma begin. A new study from the National Eye Institute reveals that myocilin—a protein linked to a significant fraction of glaucoma—is needed to insulate peri"...
DOSAGE AND ADMINISTRATION
Instill one drop into the conjunctival sac of the affected eye 4 times daily beginning 24 hours after surgery and continuing throughout the first 2 weeks of the postoperative period, followed by 2 times daily for a week and then a taper based on the response.
Endogenous Anterior Uveitis
Instill one drop into the conjunctival sac of the affected eye 4 times daily for 14 days followed by tapering as clinically indicated.
Dosage Forms And Strengths
DUREZOL contains 0.05% difluprednate as a sterile preserved emulsion for topical ophthalmic administration.
DUREZOL (difluprednate ophthalmic emulsion) 0.05% is a sterile, aqueous topical ophthalmic emulsion supplied in an opaque plastic bottle with a controlled drop tip and a pink cap in the following sizes:
5 mL in a 8 mL bottle (NDA 0065-9240-07)
5 mL in a 5 mL bottle (NDC 0065-9240-05).
Storage and Handling
Store at 15-25°C (59-77°F). Do not freeze. Protect from light. When not in use, keep the bottles in the protective carton.
Manufactured For: Alcon Laboratories, Inc., 6201 South Freeway, Fort Worth, Texas 76134 USA. Manufactured By: Alcon Laboratories, Inc., 6201 South Freeway, Fort Worth, Texas 76134 USA or Catalent Pharma Solutions, Woodstock, IL 60098. Revised: March 2013This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 1/30/2017
Additional Durezol Information
Durezol - User Reviews
Durezol User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.